Filter
1843
Filtered Results: 1843
Text search:
medicine
prices
Featured
Recommendations
165
New Publications
502
Language
Document type
No document type
964
Studies & Reports
442
Guidelines
203
Strategic & Response Plan
90
Manuals
77
Fact sheets
24
Situation Updates
18
Training Material
14
Resource Platforms
6
Infographics
3
Brochures
2
Countries / Regions
Global
89
India
59
Kenya
48
Uganda
42
South Africa
40
Nepal
39
Ukraine
39
Syria
37
Ethiopia
35
Africa
34
Liberia
32
Sierra Leone
30
Nigeria
29
Western and Central Europe
29
Zambia
25
Malawi
25
Myanmar / Burma
25
Bangladesh
24
Latin America and the Carribbean
23
Congo, Democratic Republic of
20
Ghana
19
Tanzania
18
Rwanda
18
Zimbabwe
16
Philippines
16
Mozambique
15
Venezuela
14
Eastern Europe
14
South Sudan
13
Namibia
13
South–East Asia Region
13
Cameroon
12
Haiti
12
Guinea
11
Cambodia
11
Senegal
10
Asia
10
Burkina Faso
9
Indonesia
9
Sudan
9
Yemen
9
Pakistan
8
Germany
8
Brazil
8
Russia
8
Benin
7
Botswana
7
West and Central Africa
7
Middle East and North Africa
7
Moldova
7
Lebanon
6
Central African Republic
6
Lesotho
6
East and Southern Africa
6
Tajikistan
6
Thailand
5
North America
5
USA
4
Afghanistan
4
Peru
4
Eswatini/ Swaziland
4
Eastern Europe and Central Asia
4
Paraguay
4
Albania
4
Kyrgyzstan
4
Mali
3
Somalia
3
Jordan
3
Colombia
3
Chile
3
Kazakhstan
3
Georgia
3
Vietnam
3
Turkey
2
Egypt
2
Chad
2
China
2
Papua New Guinea
2
Argentina
2
North Macedonia
2
Angola
2
Poland
2
Palestine
2
Southern Africa
2
Laos
2
Romania
2
Turkmenistan
2
Jamaica
2
Portugal
2
Spain
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
1
Niger
1
Serbia
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Sri Lanka
1
Western Pacific Region
1
Fiji
1
Bhutan
1
Mongolia
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Lithuania
1
Iran
1
Gabon
1
Japan
1
Denmark
1
France
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
701
Clinical Guidelines
157
Public Health
122
Women & Child Health
67
Key Resources
56
Pharmacy & Technologies
33
Capacity Building
8
Toolboxes
HIV
180
COVID-19
157
Mental Health
133
Pharmacy
102
AMR
81
TB
79
Conflict
74
Planetary Health
62
NCDs
55
Global Health Education
43
Disability
32
Health Financing Toolbox
31
Ebola
28
Rapid Response
27
NTDs
27
Natural Hazards
26
Refugee
25
Caregiver
25
Cholera
4
Specific Hazards
3
Social Ethics
3
Polio
1
Zika
1
Health Financing
1
Technical Update
HIV Treatment
July 2017
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
USAID Senegal and Health in Africa (HIA) initiative of the World Bank Group engaged the Strengthening Health Outcomes through the Private Sector (SHOPS) project to conduct an assessment of the private health sector in Senegal. The assessment’s primary focus is family planning, and its secondary fo...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
The arrival of COVID-19 in Afghanistan has brought heartache to millions of people who are now battling a deadly pandemic while simultaneously fighting for their survival amid poverty, disaster and war. Over my three years as Humanitarian Coordinator, I have marvelled at the resilience of the people...
The focus of the current quarterly edition of Eurohealth (from the European Observatory on Health Systems and Policies) is Antimicrobial Resistance (AMR) and contains the following articles:
• Strengthening implementation of AMR national action plans
• Fostering clinical developmen...
Sudan recorded the first COVID-19 case on 13 March 2020 and, at the beginning of July, the Federal Ministry of Health had confirmed that nearly 10,000 people had contracted the virus, including over 600 who died from the disease across the country. Although more than 70 per cent of the confirmed cas...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
Previous pandemics have demonstrated that more people could die from the indirect consequences of an outbreak than from the disease itself. As the fight against the pandemic is pushing millions into poverty and hunger, COVID-19 will likely be no different.
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
